Home Biosimilar Antibodies Metabolism LDL antibody Orticumab (Anti-oxLDL) For research use only.
Not for use in humans.

Orticumab (Anti-oxLDL)

Synonyms: MLDL1278A

Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL). Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.

Orticumab (Anti-oxLDL)

Purity & Quality Control

≥99

Choose Selective LDL Inhibitors

Biological Activity

Description Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL). Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.

Product Details

CAS No. 1314241-10-5
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Orticumab (Anti-oxLDL) | Orticumab (Anti-oxLDL) supplier | purchase Orticumab (Anti-oxLDL) | Orticumab (Anti-oxLDL) cost | Orticumab (Anti-oxLDL) manufacturer | order Orticumab (Anti-oxLDL) | Orticumab (Anti-oxLDL) distributor